| # | Drug | Count |
|---|---|---|
| 0 | BETAMETHASONE VALERATE | 1 |
| 1 | BETAMETHASONE VALERATE FOAM | 1 |
| 2 | BOTULINUM TOXIN TYPE A | 1 |
| 3 | FEZOLINETANT | 1 |
| 4 | HYDROXOCOBALAMIN | 1 |
| 5 | INFLIXIMAB | 1 |
| 6 | MEPOLIZUMAB | 1 |
| 7 | RITUXIMAB | 1 |
| 8 | SUMATRIPTAN | 1 |
| 9 | SUMATRIPTAN SUCCINATE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FEZOLINETANT | 1 | 0.0004 |
| 1 | HYDROXOCOBALAMIN | 1 | 0.0002 |
| 2 | BETAMETHASONE VALERATE FOAM | 1 | 0.0002 |
| 3 | BOTULINUM TOXIN TYPE A | 1 | 0.0001 |
| 4 | SUMATRIPTAN SUCCINATE | 1 | 0.0000 |
| 5 | SUMATRIPTAN | 1 | 0.0000 |
| 6 | MEPOLIZUMAB | 1 | 0.0000 |
| 7 | RITUXIMAB | 1 | 0.0000 |
| 8 | INFLIXIMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Neurokinin 3 Receptor Antagonist [EPC] | 1 | 0.0004 |
| 2 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 1 | 0.0000 |
| 3 | Antidote [EPC] | 1 | 0.0000 |
| 4 | Acetylcholine Release Inhibitor [EPC] | 1 | 0.0000 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 1 | 0.0000 |